CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

U S Endoscopy

Founded in 1991, US Endoscopy is a privately held, family-owned company specializing in device design and manufacturing of accessories for GI endoscopy. Marlin Younker, US Endoscopy Founder and Co-Chairman, is a respected pioneer in the industry

Ayr Wellness

Must be 21+ We aim higher for the wellness of our customers, through the power of cannabis.

Premier Healthcare Professionals

Premier Healthcare Professionals is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VersaSuite

VersaSuite is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NarrativeDx

NarrativeDx is the artificial intelligence platform for patient experience. Our SaaS platform is the market leader in transforming hospitals` clinical outcomes by extracting data trends and gaining visibility into the patient experience. We help hospital leaders and care providers understand and improve their institution`s patient experience, drive patient referrals, increase hospital revenue, and boost hospital reputations.